[go: up one dir, main page]

BR9609031A - Conjugados iónicos moleculares de derivados n-acilados de poli (2-amino-2-desóxi-d-glucose) e polipeptídeos. - Google Patents

Conjugados iónicos moleculares de derivados n-acilados de poli (2-amino-2-desóxi-d-glucose) e polipeptídeos.

Info

Publication number
BR9609031A
BR9609031A BR9609031-6A BR9609031A BR9609031A BR 9609031 A BR9609031 A BR 9609031A BR 9609031 A BR9609031 A BR 9609031A BR 9609031 A BR9609031 A BR 9609031A
Authority
BR
Brazil
Prior art keywords
deoxy
glucose
amino
polypeptides
poly
Prior art date
Application number
BR9609031-6A
Other languages
English (en)
Inventor
Shalaby W Shalaby
Steven A Jackson
Francis Ignatious
Jacques-Pierre Mareau
Original Assignee
Shalaby W Shalaby
Steven A Jackson
Francis Ignatious
Jacques Pierre Moreau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shalaby W Shalaby, Steven A Jackson, Francis Ignatious, Jacques Pierre Moreau filed Critical Shalaby W Shalaby
Publication of BR9609031A publication Critical patent/BR9609031A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polyamides (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de InvençãO:<B>"CONJUGADOS IÈNICOS MOLECULARES DE DERIVADOS N-ACILADOS DE POL (2-AMINO-2-DESóXI-D-GLUCOSE) E POLIPEPTìDEOS"<D>. Copolímiro compreendendo um derivado N-acilado, e uma composição compreendendo o referido copolímero e um polipeptídeo, o referido polipeptídeo compreendendo pelo menos uma amina ionogênica eficaz, na qual pelo menos 50% em peso do referido polipeptídeo presente na referida composição está ionicamente ligado ao referido polímero.
BR9609031-6A 1995-06-06 1996-05-24 Conjugados iónicos moleculares de derivados n-acilados de poli (2-amino-2-desóxi-d-glucose) e polipeptídeos. BR9609031A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/468,947 US5665702A (en) 1995-06-06 1995-06-06 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
PCT/US1996/007756 WO1996039160A1 (en) 1995-06-06 1996-05-24 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides

Publications (1)

Publication Number Publication Date
BR9609031A true BR9609031A (pt) 1999-12-14

Family

ID=23861854

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9609031-6A BR9609031A (pt) 1995-06-06 1996-05-24 Conjugados iónicos moleculares de derivados n-acilados de poli (2-amino-2-desóxi-d-glucose) e polipeptídeos.

Country Status (21)

Country Link
US (2) US5665702A (pt)
EP (1) EP0830137B1 (pt)
JP (1) JPH11508289A (pt)
KR (1) KR19990022399A (pt)
CN (1) CN1192152A (pt)
AT (1) ATE245031T1 (pt)
AU (1) AU717188B2 (pt)
BR (1) BR9609031A (pt)
CA (1) CA2222995C (pt)
CZ (1) CZ391697A3 (pt)
DE (1) DE69629114T2 (pt)
DK (1) DK0830137T3 (pt)
ES (1) ES2201188T3 (pt)
HU (1) HUP9901627A3 (pt)
NZ (1) NZ308909A (pt)
PL (1) PL323735A1 (pt)
PT (1) PT830137E (pt)
RU (1) RU2172323C2 (pt)
SI (1) SI9620090A (pt)
SK (1) SK168397A3 (pt)
WO (1) WO1996039160A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6479457B2 (en) * 1995-06-06 2002-11-12 Kinerton Limited Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
CN1289256A (zh) * 1998-01-29 2001-03-28 波利曼德有限公司 可吸收的微颗粒
EP1051194B9 (en) 1998-01-29 2003-11-05 Kinerton Limited Process for making absorbable microparticles
EP1992641A3 (en) 1998-12-07 2009-07-29 Ipsen Pharma GLP-1 analogues
JP4532618B2 (ja) * 1999-02-25 2010-08-25 株式会社グライコメディクス 新規糖鎖プライマー
EP1320387B1 (en) 2000-09-13 2012-04-11 Praecis Pharmaceuticals Incorporated Pharmaceutical compositions for sustained delivery of peptides
US7122622B2 (en) * 2002-04-16 2006-10-17 Biosynthema Inc. Peptide compounds having improved binding affinity to somatostatin receptors
US7244445B2 (en) 2002-07-29 2007-07-17 Poly Med, Inc Conformable, absorbable, solid composite preforms and their use for bone tissue engineering
CA2504345A1 (en) * 2002-10-31 2004-05-13 Pfizer Products Inc. Liquid conjugates of solid pharmaceuticals
CA2516056C (en) 2003-01-06 2012-05-29 Angiochem Inc. Aprotinin and analogs as carriers across the blood-brain barrier
ES2393335T3 (es) 2003-12-16 2012-12-20 Ipsen Pharma Análogos de GLP-1
ES2386862T3 (es) 2005-07-08 2012-09-03 Ipsen Pharma Ligandos de los receptores de la melanocortina
SI2233156T1 (sl) 2005-07-15 2013-09-30 Angiochem Inc. Uporaba polipeptidov aprotinina kot nosilce v farmacevtskih konjugatih
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US20100256056A1 (en) 2007-09-07 2010-10-07 Zheng Xin Dong Analogues of exendin-4 and exendin-3
AR069461A1 (es) 2007-11-05 2010-01-27 Univ Louisiana State Uso de melanocortinas para tratar la sensibilidad a insulina
US8841440B2 (en) * 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
US20110250179A1 (en) 2008-07-04 2011-10-13 Juan Carlos Lacal Sanjuan Methods for treatment and diagnosis of cancer
US8450266B2 (en) 2008-08-07 2013-05-28 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide
AU2009280021B2 (en) 2008-08-07 2012-10-04 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal
WO2010016940A2 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
EP2346896A4 (en) 2008-10-15 2014-06-25 Angiochem Inc CONJUGATES OF ETOPOSIDE AND DOXORUBICIN FOR THE ADMINISTRATION OF MEDICAMENTS
MX2011005963A (es) 2008-12-05 2011-09-01 Angiochem Inc Conjugados de neurotensina o analogos de neurotensina y sus usos.
EP2373789A4 (en) 2008-12-17 2012-08-29 Angiochem Inc MEMBRANTYP-1 MATRIX METALLOPROTEINASE INHIBITORS AND THEIR USE
WO2010092218A2 (es) 2009-02-12 2010-08-19 Proyecto De Biomedicina Cima, S.L. Uso de la cardiotrofina-1 para el tratamiento de enfermedades metabólicas
IN2012DN00248A (pt) 2009-07-02 2015-05-01 Angiochem Inc
BR112012001363A2 (pt) 2009-07-22 2016-11-08 Ipsen Pharma Sas análogo de igf-1, composição farmacêutica,e, método para tratar condições ou doenças mediadas pela ligação do receptor de igf-1
US9415012B2 (en) * 2011-06-14 2016-08-16 Ipsen Pharma S.A.S. Sustained-release composition containing peptides as active ingredient
US9962401B2 (en) * 2011-09-27 2018-05-08 Purdue Research Foundation Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles
ES2826827T3 (es) 2015-06-15 2021-05-19 Angiochem Inc Métodos para el tratamiento de carcinomatosis leptomeníngea

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS63258579A (ja) * 1987-04-15 1988-10-26 Fuji Boseki Kk 生理活性物質固定化用担体の製造法
US5271945A (en) * 1988-07-05 1993-12-21 Takeda Chemical Industries, Ltd. Sustained release microcapsule for water soluble drug
WO1992003480A1 (fr) * 1990-08-17 1992-03-05 Drug Delivery System Institute, Ltd. Derive de n-acetylcarboxymethylchitosan et procede de production
US5298488A (en) * 1990-10-26 1994-03-29 Fuji Photo Film Co., Ltd. CM-chitin derivatives and use thereof
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release

Also Published As

Publication number Publication date
EP0830137B1 (en) 2003-07-16
CN1192152A (zh) 1998-09-02
CZ391697A3 (cs) 1998-05-13
AU5878996A (en) 1996-12-24
JPH11508289A (ja) 1999-07-21
HUP9901627A3 (en) 1999-11-29
US5665702A (en) 1997-09-09
RU2172323C2 (ru) 2001-08-20
CA2222995C (en) 2005-05-10
HUP9901627A1 (hu) 1999-09-28
EP0830137A4 (en) 2002-06-26
PL323735A1 (en) 1998-04-14
KR19990022399A (ko) 1999-03-25
ATE245031T1 (de) 2003-08-15
AU717188B2 (en) 2000-03-23
DK0830137T3 (da) 2003-11-03
SK168397A3 (en) 1998-04-08
WO1996039160A1 (en) 1996-12-12
NZ308909A (en) 1999-06-29
CA2222995A1 (en) 1996-12-12
SI9620090A (sl) 1998-08-31
EP0830137A1 (en) 1998-03-25
DE69629114T2 (de) 2004-04-22
PT830137E (pt) 2003-10-31
DE69629114D1 (de) 2003-08-21
US5821221A (en) 1998-10-13
ES2201188T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
BR9609031A (pt) Conjugados iónicos moleculares de derivados n-acilados de poli (2-amino-2-desóxi-d-glucose) e polipeptídeos.
BR0007742A (pt) Conjugados iÈnicos moleculares de poliésteres biodegradáveis e polipeptìdeos bioativos
BG101095A (en) Polyethyleneglycolizing reagents and compounds produced by them
DE69702911D1 (de) Oxydierte oligosaccharide
BR9713486A (pt) Preparações farmacêuticas compreendidas de sais de ácido hialurÈnico com anestésicosm locais.
BR9811744A (pt) Conjugados contendo o homeodomìnio de antenapédia
BR9611306A (pt) Preparação farmacêutica e, composto farmacêutica estável.
BR9915515A (pt) Composições curáveis utilizando a funcionalidade de acetoacetóxi e imina
DE69525340D1 (de) Verbesserungen in zusammensetzungen von kopolymeren enthaltend kopolymer-1
NO20002547D0 (no) Poly(vinylamin)-baserte superabsorberende geler og fremgangsmÕte for fremstilling derav
EP0973819A4 (en) NON-ANTI-ACTIVE BRANCHING POLYMER CONJUGATES
BR9808965A (pt) Composições comestìveis inluindo gel particulado
RU98100091A (ru) Ионные молекулярные конъюгаты n-ацилированных производных поли(2-амино-2- деокси-d-глюкозы) и полипептидов
AU2702892A (en) Latent thiol mercaptan chain transfer agents and their use in the synthesis of polymers
NO165818C (no) I det minste delvis farvede kontaktlinser og deres fremstilling.
BR9708906A (pt) Processo para a preparação de pós polímeros redispersáveis em solução aquosa e de tamp es poliméricos pós poliméricos redispersáveis em solução aquosa utilização de pós poliméricos redispersáveis em solução aquosa e de composições tamponantes tamp es poliméricos e formulações cosméticas farmacêuticas ou para proteção de colhietas
BR0212169A (pt) Composição polimérica, processos para a preparação da mesma e de um derivado de poliisobuteno, e, derivado de poliisobuteno
ATE198834T1 (de) Konjugate bestehend aus polysaccharid und protein
ES2032211T3 (es) Un procedimiento para preparar una composicion de copolimero de bloques.
ATE148724T1 (de) Carboxyvinylpolymer mit newtonischer viskosität
PT557199E (pt) Conjugados de polietileno glicol hirudina processo de preparacao e uso na cura da trombose
BR9712733A (pt) Processo para a preparação de uma composição, composição, uso da mesma, combinação de polìmeros, e, moldado, filme ou fibra.
BR9814188A (pt) &#34;agonistas de 5-ht1f&#34;
NO20011744L (no) Ioniske molekyl¶re konjugater av N-acylerte derivater av poly(2-amino-2-deoksy-d-glukose) og polypeptider
DK563585D0 (da) Immunotoksiner med forlaenget virkning indeholdende en glycopeptidbestanddel, som inaktiverer ribosomer, og som er modificeret i sine polysaccharidenheder, og fremgangsmaade til fremstilling af immunotoksinerne

Legal Events

Date Code Title Description
PC Transfer

Free format text: BIOMEASURE INCORPORATED (US)

FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law